Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 16 entries
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Biosynthesis of cofactors 💬 10 genes, 10 drugs (DrugBank) and 51 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin Warfarin 💬Biosynthesis of cofactors
| Warfarin | 006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 86, 88, 91 💬1. Biosynthesis of cofactors
|
||||||||||||||||||||||||||||||||||||||||||||
| 2 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 37 drugs (DrugBank) and 42 diseases |
NQO1 1件: NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin Warfarin 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 86, 88, 91 💬2. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||
| 3 | Complement and coagulation cascades 💬 17 genes, 29 drugs (DrugBank) and 44 diseases |
F10 1件: F10 💬Complement and coagulation cascades
|
Rivaroxaban Rivaroxaban 💬Complement and coagulation cascades
| Rivaroxaban | 046 4件: 46, 49, 91, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 4 | Complement and coagulation cascades 💬 17 genes, 29 drugs (DrugBank) and 44 diseases |
F2 1件: F2 💬Complement and coagulation cascades
|
Dabigatran Dabigatran 💬Complement and coagulation cascades
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 5 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
F2 1件: F2 💬Coronavirus disease - COVID-19
|
Dabigatran Dabigatran 💬Coronavirus disease - COVID-19
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 6 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases |
NQO1 1件: NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin Warfarin 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 86, 88, 91 💬6. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||
| 7 | Hepatocellular carcinoma 💬 21 genes, 31 drugs (DrugBank) and 57 diseases |
NQO1 1件: NQO1 💬Hepatocellular carcinoma
|
Warfarin Warfarin 💬Hepatocellular carcinoma
| Warfarin | 006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 86, 88, 91 💬7. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||
| 8 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin Warfarin 💬Metabolic pathways
| Warfarin | 006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 86, 88, 91 💬8. Metabolic pathways
|
||||||||||||||||||||||||||||||||||||||||||||
| 9 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
F2 1件: F2 💬Neuroactive ligand-receptor interaction
|
Dabigatran Dabigatran 💬Neuroactive ligand-receptor interaction
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 10 | Pathogenic Escherichia coli infection 💬 26 genes, 39 drugs (DrugBank) and 74 diseases |
F2 1件: F2 💬Pathogenic Escherichia coli infection
|
Dabigatran Dabigatran 💬Pathogenic Escherichia coli infection
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬
|